BGB Group
BGB Group (operating as BGBx) is a New York-based, TPG-backed commercial solutions partner providing integrated strategic consulting, communications, and technology services to pharmaceutical and life sciences companies across the full brand lifecycle.
- Company typePrivate
- Founded2005
- HeadquartersNew York, United States
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
What BGB Group does
BGB Group (operating commercially as BGBx) is a New York-headquartered, privately held commercial solutions partner to the pharmaceutical and life sciences industry, founded in 2005 and backed by TPG private equity since October 2021. The company delivers integrated services across two core pillars: a Strategic Advisory consulting practice (covering corporate and portfolio strategy, new product planning, medical and evidence strategy, commercial go-to-market, pricing and market access, patient affordability and services, and intelligence and analytics) and a Communications practice (advertising, medical communications, and payer communications). The firm also maintains a Technology Suite that supports these service lines, though specific product capabilities are not publicly detailed.
The company targets enterprise pharmaceutical and life sciences clients through a direct, relationship-driven sales motion, and earns revenue primarily through professional-services engagements priced on a quote basis. Its competitive positioning is built on deep therapeutic-area expertise — particularly in oncology, rare diseases, and metabolic/bone disease — and on the integration of consulting and communications under one roof across the full brand lifecycle, from clinical development planning through market access and patient engagement. BGB has scaled to between 501 and 1,000 employees and reported $145 million in 2024 revenue (4% YoY growth), with approximately half of incremental growth sourced from new clients.
The firm's growth strategy is heavily inorganic. It acquired Kx Advisors in September 2023 to expand into healthcare strategy consulting, and acquired Hayden Consulting Group in January 2026 to add payer, reimbursement, and patient-services expertise (integrating approximately 80-100 specialists into the Strategic Advisory practice under Chief of Commercial Strategy and Innovation Hilary Gentile). The company appointed Julie Yoon as Chief Client Officer in Q4 2025 to professionalize client engagement. The combined platform now operates from offices in New York (headquarters) and Boston, with leadership including founder and managing partner Gregory Passaretti, Chief Operating Officer Teresa Day, CFO Ken Boos, and Chief Digital Officer Fred Bennett.
BGB Group firmographics
Firmographics- Name
- BGB Group
- Legal name
- BGB Group
- Website
- https://bgbgroup.com
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- BGB Group (operating as BGBx) is a New York-based, TPG-backed commercial solutions partner providing integrated strategic consulting, communications, and technology services to pharmaceutical and life sciences companies across the full brand lifecycle.
- Ownership category
- akta.pro rank
BGB Group industry classification
Industry- Product category
- Life Sciences Commercial Solutions
- NAICS
- Marketing Consulting Services (541613), Advertising Agencies (541810), Management Consulting Services (54161)
- SIC
- Services-Management Consulting Services (8742)
- akta.pro primary industry
- B2B / Account-Based Marketing (ABM) Strategy Consulting (MPAAAFAM)
- akta.pro secondary industries
- Customer Experience (CX) & Digital Experience (BPAHAEAC), B2B / Industrial Market Research (MPAAALAA)
Keywords
Where BGB Group is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
BGB Group business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Consulting Services: Strategic consulting services including corporate & portfolio strategy, new product planning, medical & evidence strategy, commercial & go-to-market strategy, pricing & market access, and patient affordability & services
- Communications Services: Advertising, medical communications, and payer communications services for life sciences companies
Go-to-market motion2 records
Distribution channels1 record
Marketing channels3 records
BGB Group product offering
Product offeringCore offering
BGB Group is a commercial solutions partner to the life sciences industry, providing integrated consulting and communications services to pharmaceutical companies. Its Consulting practice spans Corporate & Portfolio Strategy, New Product Planning, Medical & Evidence Strategy, Commercial & Go-to-Market Strategy, Pricing & Market Access, Patient Affordability & Services, and Intelligence & Analytics. Its Communications practice spans Advertising, Medical Communications (Med Comms), and Payer Communications. The firm also maintains a Technology Suite supporting these services and operates a Strategic Advisory practice strengthened by the acquisitions of Kx Advisors and Hayden Consulting Group.
Product overview
BGB Group (operating as BGBx) is a commercial solutions partner to the life sciences industry, offering an integrated portfolio of consulting and communications services. The company operates as a unified platform combining Strategic Advisory consulting services (including corporate strategy, new product planning, medical evidence strategy, commercial go-to-market, pricing and market access, and patient services) with Communications services (spanning advertising, medical communications, and payer communications). The company also maintains a Technology Suite. Recent acquisitions of Kx Advisors (healthcare strategy consultancy) and Hayden Consulting Group (market access and patient services consultancy) have expanded the firm's strategic advisory capabilities, integrating approximately 80-100 Hayden employees under Chief of Commercial Strategy and Innovation Hilary Gentile.
Differentiator
Problem solved
Functional benefit
Products and services
- Consulting Services
Quantifiable outcome
- 4% revenue growth in 2024, with nearly half of that growth coming from new clients
Companies that use BGB Group
Customer profileSegments2 records
Ideal customer profiles1 record
BGB Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
BGB Group partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Kx AdvisorscoreKx Advisors was acquired by BGB Group in September 2023. The healthcare strategy consultancy brought expertise in healthcare strategy and consulting services, expanding BGB's capabilities in the healthcare sector.
- Hayden Consulting GroupcoreHayden Consulting Group, co-founded by Jamie Sidore and David MacDougall, was acquired by BGB Group in January 2026. The premier market access and patient services consultancy specializes in payer, reimbursement, and affordability challenges for global pharmaceutical brands, integrating into BGB's Strategic Advisory practice.
Scale indicators4 records
Recent moves7 records
Expansion highlights6 records
BGB Group competitors and assessment
Company assessmentDirect peers
- ZS Associates: ZS Associates is a global consulting firm specializing in pharma strategy, market access, and commercial operations. It is a direct competitor in BGB's strategic consulting and market access service lines.
- Fingerpaint: Fingerpaint is a healthcare-focused marketing and communications agency offering strategy, creative, and omnichannel engagement. It competes directly in BGB's advertising and medical communications services.
- Trinity Life Sciences: Trinity Life Sciences provides strategic consulting, benchmarking, and insights to pharma and biotech. It competes directly with BGB's strategy consulting and intelligence & analytics practices.
- Fishawack Health: Fishawack Health is a healthcare communications and consulting group offering medical communications, consulting, and creative services to pharma. It competes directly in BGB's medical communications and strategy consulting lines.
- EVERSANA: EVERSANA is an independent pharma services platform spanning market access, patient services, and commercial strategy. It is highly comparable to BGB's integrated strategic advisory offering, particularly post-Hayden acquisition.
- Lumanity: Lumanity is a life sciences consulting and commercialization firm focused on strategy, evidence, and access. It competes in BGB's strategic advisory space, particularly in evidence strategy and market access.
- Syneos Health: Syneos Health is a large pharma services platform combining commercial strategy, medical communications, and clinical capabilities. It is directly comparable as an integrated commercialization partner serving the same pharma/life sciences buyer base.
- Publicis Health: Publicis Health is a healthcare-focused communications and advertising network within Publicis Groupe, competing directly in medical communications, payer communications, and HCP engagement services for pharma clients.
Broad incumbents
- IQVIA: IQVIA is a global leader in life sciences data, analytics, and consulting, with broad capabilities across commercial strategy, market access, and R&D. It is a broad incumbent overlapping multiple BGB service lines.
- Accenture Life Sciences: Accenture's Life Sciences practice offers strategy, consulting, and digital transformation services to pharma. It is a broader incumbent competing for enterprise pharma transformation and consulting engagements.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
BGB Group social profiles
Digital presenceBGB Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
BGB Group leadership team
Management profileNumber of profiles
Profiles6 records
BGB Group subsidiaries and ownership
Company hierarchySubsidiaries2 records
BGB Group funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BGB Group M&A and investment
M&A and investmentM&A2 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BGB Group
What does BGB Group do?
BGB Group is a commercial solutions partner to the life sciences industry, providing integrated consulting and communications services to pharmaceutical companies. Its Consulting practice spans Corporate & Portfolio Strategy, New Product Planning, Medical & Evidence Strategy, Commercial & Go-to-Market Strategy, Pricing & Market Access, Patient Affordability & Services, and Intelligence & Analytics. Its Communications practice spans Advertising, Medical Communications (Med Comms), and Payer Communications. The firm also maintains a Technology Suite supporting these services and operates a Strategic Advisory practice strengthened by the acquisitions of Kx Advisors and Hayden Consulting Group.
Is BGB Group a public or private company?
BGB Group is a private company. It is classified as private equity controlled and is currently operating.
When was BGB Group founded?
BGB Group was founded in 2005. It employs 501 to 1,000 people.
Where is BGB Group based?
BGB Group is headquartered in New York, United States, in the North America region.
How does BGB Group make money?
Two revenue lines are on record. Consulting Services are the primary driver. The others are communications Services.
Who are BGB Group's main competitors?
Direct peers on record are ZS Associates, Fingerpaint, Trinity Life Sciences, Fishawack Health, EVERSANA, Lumanity, Syneos Health and Publicis Health. Broad incumbents are IQVIA and Accenture Life Sciences.
Does BGB Group have an API?
No public API is recorded for BGB Group.
What industry is BGB Group in?
BGB Group's product category is Life Sciences Commercial Solutions. Its primary akta.pro industry code is MPAAAFAM, B2B / Account-Based Marketing (ABM) Strategy Consulting, with a secondary code of BPAHAEAC, Customer Experience (CX) & Digital Experience. Its NAICS code is 541613 and its SIC code is 8742.